Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-28 · accession 0001127602-24-007621 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-29 | 2024-02-28 | LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory, QA | M - OptEx | — | +67.4K | 126.7K | +114% | — |
| D | 2024-02-29 | 2024-02-28 | LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory, QA | F - Tax | $2.62 | -24.4K | 162.7K | -13% | -$63.8K |
| DM | 2024-02-29 | 2024-02-28 | LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory, QA | M - OptEx | — | -67.4K | 65.5K | -51% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | M | A | 32,757 | — | 187,025 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 2 | Common | Common Stock | 2024-02-28 | M | A | 27,556 | — | 154,268 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 3 | Common | Common Stock | 2024-02-28 | M | A | 7,087 | — | 126,712 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 4 | Common | Common Stock | 2024-02-28 | F | D | 24,353 | $2.62 | 162,672 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2024-02-28 | M | D | 7,087 | — | 0 | D | — · — to — | 7,087 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 6 | Derivative | Restricted Stock Units | 2024-02-28 | M | D | 27,556 | — | 27,557 | D | — · — to — | 27,556 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 7 | Derivative | Restricted Stock Units | 2024-02-28 | M | D | 32,757 | — | 65,513 | D | — · — to — | 32,757 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |